Intelligent Bio Solutions...

NASDAQ: INBS · Real-Time Price · USD
1.47
-0.03 (-2.00%)
At close: Aug 19, 2025, 3:59 PM
1.46
-0.34%
Pre-market: Aug 20, 2025, 08:03 AM EDT

Intelligent Bio Solutions Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
-3.1M -2.55M -2.26M -2.69M -2.8M -2.98M -1.98M -2.43M -2.67M -6.35M -427.07K -1.21M -2.09M -1.34M -3.46M -1.44M -850.23K -3.14M -1.99M -1.07M
Depreciation & Amortization
306.17K 296.83K 307.63K 303.11K 287.69K 327.52K 290.31K 307.56K 170.07K 398.5K -398.16K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
12K 12K 12K 202.04K 12.19K 218.31K n/a n/a 260K -260K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
-300.66K -517.86K -47.66K -189.57K 394.5K -18.59K 513.38K -889.28K 1.29M -615.86K 597.18K -633.23K -637.97K 841.08K -84.33K 2.08M -843.77K -3.1M n/a n/a
Other Non-Cash Items
277.34K -5.79K 51.28K -119.21K 80.06K 761.99K -176.48K 7.56K -122.73K 3.79M -591.92K -33.13K 232.07K -257.09K 2.54M 23.25K -66.95K -253.62K 943.55K 81.38K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a -260K 260K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
297.14K -507.75K -438.87K -78.37K -530.18K 28.99K -1.01M 805.47K 2.04M -350.56K -963.71K -646.53K 132.9K 1.31M -500.38K 1.5M -765.63K -2.76M 339.79K -1.75M
Operating Cash Flow
-2.21M -2.76M -2.32M -2.39M -2.94M -2.47M -2.87M -1.31M -584.34K -2.52M -2.38M -1.89M -1.72M -292.22K -1.43M 82.96K -1.68M -6.16M -711.45K -2.74M
Capital Expenditures
-231.84K n/a n/a n/a -167.31K 2.42K -56.67K n/a 505.12K -678 -29.55K -474.89K -203.01K n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a -181.75K 174.48K -178.34K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
23.32K n/a n/a n/a -216.06K n/a n/a n/a -505.12K n/a -3.41K n/a -500K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-208.52K -14.38K -8.94K n/a -167.31K 2.42K -56.67K n/a -181.75K 173.8K -211.3K -474.89K -703.01K n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a -65.53K -34.11K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -14.41K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-23.3K 20.63K -20.63K 7.94K 5.31K 9.15M 3.79M n/a 46.11K -771.31K -14.14K n/a n/a n/a n/a n/a n/a 498.1K 19.61M n/a
Financial Cash Flow
602K 3.32M 631.74K 42.45K 5.31K 10.82M 3.79M n/a 46.11K 1.72M -328.41K n/a n/a n/a n/a n/a n/a 498.1K 19.61M 3.29M
Net Cash Flow
-1.79M 564.9K -1.75M -2.31M -3.09M 8.28M 932.6K -1.35M -743.3K -631.14K -2.83M -2.5M -2.52M -434.53K -1.42M 34.78K -1.69M -5.62M 18.88M 566.91K
Free Cash Flow
-2.44M -2.76M -2.32M -2.39M -3.11M -2.46M -2.93M -1.31M -79.22K -2.52M -2.41M -2.37M -1.93M -292.22K -1.43M 82.96K -1.68M -6.16M -711.45K -2.74M